InvestSMART

Tetratherix Limited (ASX: TTX) - Announcements

Current share price for TTX : $6.435 0.185 (2.96%)+

ASX company news and announcements for Tetratherix Limited (TTX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Tetratherix Limited (TTX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Tetratherix Limited (TTX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Tetratherix Limited (TTX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$190 STRONGER ECONOMICS, LOCAL ECOSYSTEM EXPANSION 9 Nov 2026 9:22AM $5.800 $6.435 risen by 10.95%
$190 Application for quotation of securities - TTX 4 Nov 2026 10:57AM $5.550 $6.435 risen by 15.95%
$190 Details of Auditor Appointment/Resignation 30 Oct 2026 2:54PM $5.490 $6.435 risen by 17.21%
$190 Quarterly Activities/Appendix 4C Cash Flow Report 30 Oct 2026 8:36AM $5.350 $6.435 risen by 20.28%
$190 TegenEOS Biologic Pathway 29 Oct 2026 10:13AM $5.700 $6.435 risen by 12.89%
$190 Notification of cessation of securities - TTX 21 Oct 2026 5:13PM $5.400 $6.435 risen by 19.17%
$190 Application for quotation of securities - TTX 21 Oct 2026 5:01PM $5.400 $6.435 risen by 19.17%
$190 Notice of Annual General Meeting/Proxy Form 12 Oct 2026 1:27PM $6.590 $6.435 fallen by 2.35%
$190 Application for quotation of securities - TTX 7 Oct 2026 4:38PM $6.630 $6.435 fallen by 2.94%
$190 Tegenix FDA Review Progress 6 Oct 2026 8:56AM $6.380 $6.435 risen by 0.86%
$190 Notification regarding unquoted securities - TTX 2 Oct 2026 10:47AM $6.400 $6.435 risen by 0.55%
$190 Line of sight ophthalmic tissue spacing US revenue 16 Sep 2026 8:33AM $6.340 $6.435 risen by 1.50%
$190 Tetratherix Ships First US Polymer, Revenue Begins 31 Aug 2026 8:28AM $6.930 $6.435 fallen by 7.14%
$190 Application for quotation of securities - TTX 24 Aug 2026 11:51AM $6.350 $6.435 risen by 1.34%
$190 Results Presentation 2026 20 Aug 2026 1:07PM $6.120 $6.435 risen by 5.15%
$190 Appendix 4E and Annual Report 2026 20 Aug 2026 9:05AM $5.850 $6.435 risen by 10%
$190 Quarterly Activities/Appendix 4C Cash Flow Report 22 Jul 2026 8:24AM $6.750 $6.435 fallen by 4.67%
$190 Notification regarding unquoted securities - TTX 1 Jul 2026 1:53PM $6.000 $6.435 risen by 7.25%
$190 Tutela Interim Study Results 23 Jun 2026 9:53AM $5.920 $6.435 risen by 8.70%
$190 Application for quotation of securities - TTX 23 Jun 2026 8:15AM $5.920 $6.435 risen by 8.70%
$190 SPP Results 22 Jun 2026 8:17AM $5.920 $6.435 risen by 8.70%
$190 Application for quotation of securities - TTX 19 Jun 2026 8:19AM $6.000 $6.435 risen by 7.25%
$190 Mandatory Escrow Release 9 Jun 2026 10:46AM $5.880 $6.435 risen by 9.44%
$190 Study Results Peptide-Polymer Patents 9 Jun 2026 8:33AM $5.900 $6.435 risen by 9.07%
$190 SPP Booklet 4 Jun 2026 9:16AM $6.300 $6.435 risen by 2.14%

1 - 25 of 138 results

Page 1 of 6

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.